SCHEMBL25590474

SCHEMBL25590474

Cc1ccc(NC(=O)c2nc(-c3cncnc3)ccc2C)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 3/20 0.51
▸ ABL1 P00519 4/20 0.44
▸ NPC1 O15118 5/20 0.44
▸ RAB9A P51151 5/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ MAPT P10636 3/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ PDGFRB P09619 1/20 0.43
▸ BCR P11274 1/20 0.43
▸ PDGFRA P16234 1/20 0.43
▸ TP53 P04637 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ NAMPT P43490 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ P4HTM Q9NXG6 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25590383 0.90 ATR (0.49) ATRABL1NPC1RAB9ASMN1; SMN2
SCHEMBL25593238 0.87 ABL1 (0.47) ATRABL1NPC1RAB9ASMN1; SMN2
SCHEMBL25590685 0.86 ATR (0.46) ATRABL1RAB9AMAPTKMT2A
SCHEMBL25590481 0.84 SMN1; SMN2 (0.47) ATRABL1NPC1RAB9ASMN1; SMN2
SCHEMBL25590670 0.83 ABL1 (0.47) ATRABL1NPC1RAB9ASMN1; SMN2
SCHEMBL25590895 0.80 CLK2 (0.44) ATRABL1MAPTNAMPT
SCHEMBL25590897 0.80 ALDH1A1 (0.47) ATRNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL25593788 0.79 ATR (0.48) ATRNPC1RAB9ASMN1; SMN2TP53
SCHEMBL25590392 0.78 STING1 (0.49) ATRMAPTTP53
SCHEMBL25216493 0.77 ATR (0.41) ATRRAB9ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023088435-A1 PREPARATION FOR TRISUBSTITUTED PYRIDINE DERIVATIVE AND APPLICATION AS AROMATIC HYDROCARBON RECEPTOR MODULATOR 成都奥睿药业有限公司 2023-05-25 — — WO disclosed
Send feedback